Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Nov 07, 2023

SELL
$23.85 - $31.34 $13,594 - $17,863
-570 Closed
0 $0
Q4 2022

Nov 07, 2023

SELL
$17.65 - $27.37 $3,565 - $5,528
-202 Reduced 26.17%
570 $15 Million
Q3 2022

Nov 07, 2023

SELL
$22.62 - $32.54 $248 - $357
-11 Reduced 1.4%
772 $17.9 Million
Q2 2022

Nov 07, 2023

BUY
$22.88 - $39.45 $7,275 - $12,545
318 Added 68.39%
783 $19.7 Million
Q1 2022

Nov 07, 2023

BUY
$31.69 - $43.29 $14,387 - $19,653
454 Added 4127.27%
465 $17.8 Million
Q4 2021

Nov 07, 2023

SELL
$35.2 - $52.6 $19,008 - $28,404
-540 Reduced 98.0%
11 $432,000
Q3 2021

Nov 07, 2023

BUY
$46.35 - $59.75 $927 - $1,195
20 Added 3.77%
551 $26.9 Million
Q2 2021

Nov 07, 2023

BUY
$47.2 - $67.81 $25,063 - $36,007
531 New
531 $27.9 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.3B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.